News and Trends 14 Dec 2021 ATP Blazes US Venture Capital Trail into European Biotech Startups The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray by launching the UK immuno-oncology company Adrendra Therapeutics. This happens as US investors increasingly search for value-for-money opportunities in early-stage European biotech startups. Last week, the life science-focused investor ATP contributed €47M (£40M) to the Series A launch of immunotherapy […] December 14, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 10 Dec 2021 European Biotech Investors Cap Off Record Year in Fundraising The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health Ventures, and Merck’s venture capital arm M Ventures raise impressive funds to speed up life sciences innovation. This year is set to break records in terms of the money flowing into institutional life science investors. With 2021 not even finished, […] December 10, 2021 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Dec 2021 Sanifit Seals Booming Acquisition Year for Spanish Life Sciences The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high point for the life sciences sector in Spain, which has seen a burst of acquisitions this year. Last month, Vifor Pharma acquired Sanifit in a deal worth up to €375M, hailed as one of the biggest-ever biotech acquisitions in Spain. […] December 3, 2021 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 4 Aug 2021 Ditch the VC: Alternative Funding Options for Biotech Startups Getting money for a biotech startup can be a daunting task. Venture capital is not the only — and not always the best — option to fund a life sciences company. “A lot of entrepreneurs, particularly young first-time entrepreneurs, think venture capital is the only way to build up a company,” said Andreas Schmidt. Ten […] August 4, 2021 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 7 Jul 2021 Three Lessons an Investor Can Learn from Biotech Entrepreneurs Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing its entrepreneurs and how their years of experience provide a source of inspiration for venture capitalists. Every time I walk through our Paris office, I am greeted by a wall of photos showcasing some of the top entrepreneurial minds that […] July 7, 2021 - 7 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
Opinion 8 Mar 2021 Advice for my Younger Self: How to Be a VC in Life Sciences Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was two decades ago and shares what he would tell his younger self about being a life sciences VC. I am not a scientist or a doctor. Twenty years ago, when I was starting my career in this business, someone like […] March 8, 2021 - 5 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
Expert Advice 26 Aug 2020 Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur There is usually a big disparity between investors and entrepreneurs regarding the valuation of an early-stage biotech company. How can both sides navigate this negotiation and reach a fair agreement? Many entrepreneurs in biotech might be puzzled when they get a low pre-money valuation for a product with high potential. Even when a product in […] August 26, 2020 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 4 May 2020 How Are Biotech VC Investments Changing with Covid-19? Covid-19 has been dominating the news for weeks on end, but what impact is the current pandemic having on biotech VC investments? Some key figures working in the field in Europe discussed their recent experiences, as well as advice for startups navigating this new funding challenge. The coronavirus pandemic has impacted us all in ways […] May 4, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Expert Advice 6 Apr 2020 How Investors Can Prepare for the Digitization of Biotech For a few decades, the worlds of biotech and digital technology have been on separate paths. Franck Lescure, Partner at the French VC firm Elaia Partners, explains how the two fields are now colliding and how investors need to catch up. At first glance, digital technology and biotech are widely different fields, each with their […] April 6, 2020 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 11 Feb 2020 Why European Biotechs Should Look to China for Investment Traditionally European biotechs have looked to the US for additional investment, but changes in the law and significant economic success in the country in recent years means that new opportunities are opening up in China that are ripe for exploitation. China has a massive population and a correspondingly large patient group. Homegrown science is pretty […] February 11, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 17 Oct 2019 Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage healthcare companies, bringing the total capital managed by the firm to €2B. Sofinnova Partners aims to invest around two-thirds of the new fund, called Sofinnova Capital IX, in European life science companies. The other third will be invested globally, with […] October 17, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jul 2019 Wellington Partners Raises €210M to Invest in European Life Sciences VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science companies, with a major focus on those located in German-speaking countries. Wellington Partners has well surpassed its initial target of €150M for its fifth life sciences fund. With a total €210M raised, this new fund is more than double the […] July 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email